Bio-Medical Applications Of Alabama, Inc in Meridianville, Alabama - Dialysis Center

Bio-Medical Applications Of Alabama, Inc is a medicare approved dialysis facility center in Meridianville, Alabama and it has 21 dialysis stations. It is located in Madison county at 11839 Highway 231-431 North, Meridianville, AL, 35759. You can reach out to the office of Bio-Medical Applications Of Alabama, Inc at (256) 828-3128. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Alabama, Inc has the following ownership type - Profit. It was first certified by medicare in September, 2015. The medicare id for this facility is 012681 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Alabama, Inc
Location	11839 Highway 231-431 North, Meridianville, Alabama
No. of Dialysis Stations	21
Medicare ID	012681
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Alabama, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1003207176
Organization Name	Fresenius Medical Care Tranquility
Doing Business As	Bio-medical Applications Of Alabama, Inc.
Address	11839 Hwy 231-431 N Meridianville, Alabama, 35759
Phone Number	(256) 828-3128

Dialysis patients with Hemoglobin data	27
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	4

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	58
  Adult patient months included in Kt/V greater than or equal to 1.2	483
  Percentage of adult patients getting regular hemodialysis at the center	100
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Alabama, Inc with elevated calcium levels.

Patients with hypercalcemia	62
Hypercalcemia patient months	509
Patients with Serumphosphor	66
Patients with Serumphosphor less than 3.5 mg/dL	7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	25
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	26
Patients with Serumphosphor from 5.6 to 7 mg/dL	19
Patients with Serumphosphor greater than 7 mg/dL	22

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	50
Patient months included in arterial venous fistula and catheter summaries	364
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	60
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	11

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	38
Hospitalization Rate in facility	149.4 (As Expected)
Hospitalization Rate: Upper Confidence Limit	304.1
Hospitalization Rate: Lower Confidence Limit	77.7

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Alabama, Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) Year	January, 2016 - December, 2016
Readmission Rate in facility	43.8 (Worse than Expected)
Readmission Rate: Upper Confidence Limit	59.7
Readmission Rate: Lower Confidence Limit	30